manganese has been researched along with Adenoma, Islet Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 1 |
| Caseiro-Alves, F; Coffin, C; Diche, T; Kobeiter, H; Mahfouz, A; Mathieu, D; Rahmouni, A | 1 |
1 review(s) available for manganese and Adenoma, Islet Cell
| Article | Year |
|---|---|
Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Topics: Adenoma, Islet Cell; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Preoperative Care; Pyridoxal Phosphate | 1999 |
1 other study(ies) available for manganese and Adenoma, Islet Cell
| Article | Year |
|---|---|
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Water; Brain; Carcinoid Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Image Enhancement; Infusions, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pyridoxal Phosphate; Safety; Sensitivity and Specificity; Time Factors | 1998 |